Skip to main content
. 2015 Aug 4;2015(8):CD006731. doi: 10.1002/14651858.CD006731.pub2
Section/Topic # Checklist item Reported on page #
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g. publication bias, selective reporting within studies) Yes
Additional analyses 16 Describe methods of additional analyses (e.g. sensitivity or subgroup analyses, meta‐regression), if done, indicating which were prespecified Yes
RESULTS  
Study selection 17 Give numbers of studies screened, assessed for eligibility and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram Yes. In the text ‐ also "Characteristics of excluded studies"
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g. study size, PICOS, follow‐up period) and provide the citations Yes
Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12) Additional Tables 3, 4; Appendices 4, 5
Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study, the following: (a) simple summary data for each intervention group, and (b) effect estimates and confidence intervals, ideally with a forest plot Tables of "Characteristics of included studies"
Synthesis of results 21 Present results of each meta‐analysis done, including confidence intervals and measures of consistency N/A
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15) Summary of findings tables
Additional analysis 23 Give results of additional analyses, if done (e.g. sensitivity or subgroup analyses, meta‐regression [see Item 16]) Tables 6 to 10
DISCUSSION  
Summary of evidence 24 Summarise the main findings including strength of the evidence for each main outcome; consider their relevance to key groups (e.g. healthcare providers, users and policy makers) Yes
Limitations 25 Discuss limitations at study and outcome levels (e.g. risk of bias) and at review level (e.g. incomplete retrieval of identified research, reporting bias) Yes
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research Yes
FUNDING  
Funding 27 Describe sources of funding for the systematic review and other support (e.g. supply of data); the role of funders for the systematic review Yes
HHS Vulnerability Disclosure